December 21, 2012 / 6:30 AM / 5 years ago

BRIEF-EC approves Novartis drug exjade for iron overload

ZURICH, Dec 21 (Reuters) - Novartis AG : * Says European commission approves exjade for iron overload in thalassemia patients with non-transfusion-dependent thalassemia

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below